Glycation alters ligand binding, enzymatic, and pharmacological properties of human albumin

Biochemistry

Volumn 54, Issue 19, 2015, Pages 3051-3062

  Baraka Vidot, Jennifer ^a,b   Planesse, Cynthia ^a,b   Meilhac, Olivier ^a,b,c   Militello, Valeria ^d   Van Den Elsen, Jean ^e   Bourdon, Emmanuel ^a,b   Rondeau, Philippe ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE LA RÉUNION   (France)

^c CHU de la Réunion Centre d'Investigation Clinique ^*  (France)

^d UNIVERSITY OF PALERMO   (Italy)

^e University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; ENZYMES; ESTERS; FLUORESCENCE SPECTROSCOPY; GLUCOSE; LEAST SQUARES APPROXIMATIONS; PROTEINS; REGRESSION ANALYSIS;

BIOCHEMICAL PROPERTIES; FUNCTIONAL PROPERTIES; OXIDATIVE PARAMETERS; P-NITROPHENYL ACETATE; PARTIAL LEAST SQUARES REGRESSION ANALYSIS; PHARMACOLOGICAL ACTIVITY; PHARMACOLOGICAL PROPERTIES; PROTEIN AGGREGATION;

GLYCOSYLATION;

4 NITROPHENYL ACETATE; ACETIC ACID DERIVATIVE; ESTERASE; GLUCOSE; HEMOGLOBIN A1C; HUMAN ALBUMIN; KETOPROFEN; NITRO DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG; ALBUMINOID; GLYCOSYLATED SERUM ALBUMIN; PROTEIN BINDING; SERUM ALBUMIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIABETIC PATIENT; FLUORESCENCE SPECTROSCOPY; GLYCATION; HUMAN; HYDROLYSIS; LIGAND BINDING; MOLECULAR WEIGHT; OXIDATION REDUCTION STATE; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; AFFINITY CHROMATOGRAPHY; CHEMISTRY; GLYCOSYLATION; MASS SPECTROMETRY; METABOLISM; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY;

ALBUMINS; CHROMATOGRAPHY, AFFINITY; GLYCOSYLATION; HUMANS; KETOPROFEN; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE;

EID: 84929577149     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00273     Document Type: Article

References (62)

1. Guthrow, C. E., Morris, M. A., Day, J. F., Thorpe, S. R., and Baynes, J. W. (1979) Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus Proc. Natl. Acad. Sci. U.S.A. 76, 4258-4261
2. Maillard, L. (1912) Action des acides aminés sur les sucres. In Formation des mélanoïdes par voie méthodique, pp 66-68, CRA, Paris.
3. Brownlee, M. (1995) The pathological implications of protein glycation Clin. Invest. Med. 18, 275-281
4. Hartog, J. W., Voors, A. A., Bakker, S. J., Smit, A. J., and van Veldhuisen, D. J. (2007) Advanced glycation end-products (AGEs) and heart failure: Pathophysiology and clinical implications Eur. J. Heart Failure 9, 1146-1155
5. Anguizola, J. A., Basiaga, S. B., and Hage, D. S. (2013) Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin Curr. Metabolomics 1, 239-250
6. Rondeau, P. and Bourdon, E. (2011) The glycation of albumin: Structural and functional impacts Biochimie 93, 645-658
7. Armbruster, D. A. (1987) Fructosamine: Structure, analysis, and clinical usefulness Clin. Chem. 33, 2153-2163
8. Halliwell, B. (1988) Albumin: An important extracellular antioxidant? Biochem. Pharmacol. 37, 569-571
9. Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., and Curry, S. (2005) Structural basis of the drug-binding specificity of human serum albumin J. Mol. Biol. 353, 38-52
10. Bi, S., Yan, L., Sun, Y., and Zhang, H. (2010) Investigation of ketoprofen binding to human serum albumin by spectral methods Spectrochim. Acta, Part A 78, 410-414
11. Joseph, K. S. and Hage, D. S. (2010) The effects of glycation on the binding of human serum albumin to warfarin and l -tryptophan J. Pharm. Biomed. Anal. 53, 811-818
12. Kragh-Hansen, U. (1990) Structure and ligand binding properties of human serum albumin Dan. Med. Bull. 37, 57-84
13. Sudlow, G., Birkett, D. J., and Wade, D. N. (1976) Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12, 1052-1061
14. Lagrange, F., Penhourcq, F., Matoga, M., and Bannwarth, B. (2000) Binding of ketoprofen enantiomers in various human albumin preparations J. Pharm. Biomed. Anal. 23, 793-802
15. Ikeda, K. and Kurono, Y. (1986) Enzymatic activity and drug binding activity of human serum albumin Yakugaku Zasshi 106, 841-855
16. Honma, K., Nakamura, M., and Ishikawa, Y. (1991) Acetylsalicylate-human serum albumin interaction as studied by NMR spectroscopy: Antigenicity-producing mechanism of acetylsalicylic acid Mol. Immunol. 28, 107-113
17. Yang, F., Bian, C., Zhu, L., Zhao, G., Huang, Z., and Huang, M. (2007) Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin J. Struct. Biol. 157, 348-355
18. Watanabe, H., Tanase, S., Nakajou, K., Maruyama, T., Kragh-Hansen, U., and Otagiri, M. (2000) Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity Biochem. J. 349, 813-819
19. Baraka-Vidot, J., Guerin-Dubourg, A., Dubois, F., Payet, B., Bourdon, E., and Rondeau, P. (2013) New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities Biochim. Biophys. Acta 1830, 3532-3541
20. Baraka-Vidot, J., Guerin-Dubourg, A., Bourdon, E., and Rondeau, P. (2012) Impaired drugs-binding capacities of in vitro and in vivo glycated albumin Biochimie 94, 1960-1967
21. Guerin-Dubourg, A., Catan, A., Bourdon, E., and Rondeau, P. (2012) Structural modifications of human albumin in diabetic context Diabetes Metab. 38, 171-178
22. Rondeau, P., Singh, N., Caillens, H., and Bourdon, E. (2008) Oxidative stresses induced by glycated human or bovine serum albumins on human monocytes Free Radical Biol. Med. 45, 799-812
23. Johnson, R. N., Metcalf, P. A., and Baker, J. R. (1983) Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control Clin. Chim. Acta 127, 87-95
24. Snyder, S. L. and Sobocinski, P. Z. (1975) An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines Anal. Biochem. 64, 284-288
25. Rondeau, P., Navarra, G., Cacciabaudo, F., Leone, M., Bourdon, E., and Militello, V. (2010) Thermal aggregation of glycated bovine serum albumin Biochim. Biophys. Acta 1804, 789-798
26. Ellman, G. L. (1959) Tissue sulfhydryl groups Arch. Biochem. Biophys. 82, 70-77
27. Chesne, S., Rondeau, P., Armenta, S., and Bourdon, E. (2006) Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells Biochimie 10, 1467-1477
28. Levine, R. L., Williams, J. A., Stadtman, E. R., and Shacter, E. (1994) Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol. 233, 346-357
29. Baraka-Vidot, J., Navarra, G., Leone, M., Bourdon, E., Militello, V., and Rondeau, P. (2014) Deciphering metal-induced oxidative damages on glycated albumin structure and function Biochim. Biophys. Acta 1840, 1712-1724
30. Levine, R. L., Wehr, N., Williams, J. A., Stadtman, E. R., and Shacter, E. (2000) Determination of carbonyl groups in oxidized proteins Methods Mol. Biol. 99, 15-24
31. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227, 680-685
32. Morais, M. P., Mackay, J. D., Bhamra, S. K., Buchanan, J. G., James, T. D., Fossey, J. S., and van den Elsen, J. M. (2009) Analysis of protein glycation using phenylboronate acrylamide gel electrophoresis Proteomics 10, 48-58
33. Fairbanks, V. F. and Zimmerman, B. R. (1983) Measurement of glycosylated hemoglobin by affinity chromatography Mayo Clin. Proc. 58, 770-773
34. Meerwaldt, R., Links, T., Graaff, R., Thorpe, S. R., Baynes, J. W., Hartog, J., Gans, R., and Smit, A. (2005) Simple noninvasive measurement of skin autofluorescence Ann. N.Y. Acad. Sci. 1043, 290-298
35. Schmitt, A., Schmitt, J., Munch, G., and Gasic-Milencovic, J. (2005) Characterization of advanced glycation end products for biochemical studies: Side chain modifications and fluorescence characteristics Anal. Biochem. 338, 201-215
36. Bar-Or, D., Lau, E., and Winkler, J. V. (2000) A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: A preliminary report The Journal of Emergency Medicine 19, 311-315
37. Lee, E., Eom, J. E., Jeon, K. H., Kim, T. H., Kim, E., Jhon, G. J., and Kwon, Y. (2014) Evaluation of albumin structural modifications through cobalt-albumin binding (CAB) assay J. Pharm. Biomed. Anal. 91, 17-23
38. Kurono, Y., Kushida, I., Tanaka, H., and Ikeda, K. (1992) Esterase-like activity of human serum albumin. VIII. Reaction with amino acid p-nitrophenyl esters Chem. Pharm. Bull. 40, 2169-2172
39. Ozeki, Y., Kurono, Y., Yotsuyanagi, T., and Ikeda, K. (1980) Effects of drug binding on the esterase activity of human serum albumin: Inhibition modes and binding sites of anionic drugs Chem. Pharm. Bull. 28, 535-540
40. Rondeau, P., Jhurry, D., Sers, S., and Cadet, F. (2004) Study of the interactions between sucrose and metal ions (Mg2+ and K+) and their simultaneous quantification in ternary mixture by mid-infrared and 13C nuclear magnetic resonance spectroscopies Appl. Spectrosc. 58, 816-822
41. Rondeau, P., Sers, S., Jhurry, D., and Cadet, F. (2002) Indirect metal ions (K+, Na+, Mg2+ and Ca2+) quantification from infrared spectroscopy Appl. Spectrosc. Rev. 37, 119-136
42. Bouma, B., Kroon-Batenburg, L. M., Wu, Y. P., Brunjes, B., Posthuma, G., Kranenburg, O., de Groot, P. G., Voest, E. E., and Gebbink, M. F. (2003) Glycation induces formation of amyloid cross-β structure in albumin J. Biol. Chem. 278, 41810-41819
43. Khan, M. W., Rasheed, Z., Khan, W. A., and Ali, R. (2007) Biochemical, biophysical, and thermodynamic analysis of in vitro glycated human serum albumin Biochemistry (Moscow) 72, 146-152
44. Sattarahmady, N., Moosavi-Movahedi, A. A., Habibi-Rezaei, M., Ahmadian, S., Saboury, A. A., Heli, H., and Sheibani, N. (2008) Detergency effects of nanofibrillar amyloid formation on glycation of human serum albumin Carbohydr. Res. 343, 2229-2234
45. Presle, N., Lapicque, F., Fournel-Gigleux, S., Magdalou, J., and Netter, P. (1996) Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism Drug Metab. Dispos. 24, 1050-1057
46. Cohen, M. P. (2003) Intervention strategies to prevent pathogenetic effects of glycated albumin Arch. Biochem. Biophys. 419, 25-30
47. Tillement, J. P., Lhoste, F., and Giudicelli, J. F. (1978) Diseases and drug protein binding Clin. Pharmacokinet. 3, 144-154
48. Kragh-Hansen, U., Chuang, V. T., and Otagiri, M. (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol. Pharm. Bull. 25, 695-704
49. Dubois-Presle, N., Lapicque, F., Maurice, M. H., Fournel-Gigleux, S., Magdalou, J., Abiteboul, M., Siest, G., and Netter, P. (1995) Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide Mol. Pharmacol. 47, 647-653
50. Rainsford, K. D., Ford, N. L., Brooks, P. M., and Watson, H. M. (1980) Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: Characterization and the importance of the enzymic components Eur. J. Clin. Invest. 10, 413-420
51. Salvi, A., Carrupt, P. A., Mayer, J. M., and Testa, B. (1997) Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid Drug Metab. Dispos. 25, 395-398
52. Stolzing, A., Widmer, R., Jung, T., Voss, P., and Grune, T. (2006) Degradation of glycated bovine serum albumin in microglial cells Free Radical Biol. Med. 40, 1017-1027
53. Wei, Y., Chen, L., Chen, J., Ge, L., and He, R. (2009) Rapid glycation with d -ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells BMC Cell Biol. 10, 10
54. Lakowitcz, J. (2006) Principles of Fluorescence Spectroscopy, Spinger, New York.
55. Thomas, M., Nelson, G., Patonay, G., and Warner, I. (1988) Analysis of drug binding sites on human serum albumin using multidimensional fluorescence measurements Spectrochim. Acta, Part B 43, 651-660
56. Peters, T. J. (1996) All about albumin: Biiochemistry, Genetics, and Medical Applications, Academic Press, San Diego.
57. Oettl, K. and Stauber, R. E. (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br. J. Pharmacol. 151, 580-590
58. Wolfbeis, O. S. and Gurakar, A. (1987) The effect of fatty acid chain length on the rate of arylester hydrolysis by various albumins Clin. Chim. Acta 164, 329-337
59. Baraka-Vidot, J., Denemont, I., Ali Mcolo, Z., Bourdon, E., and Rondeau, P. (2015) Ammonium Sulfate Precipitation but not Delipidation is a Good Method for Human Albumin Preparation for Biological Studies International Journal of Diabetes & Clinical Diagnosis 2, 109
60. Yoshida, K., Kurono, Y., Mori, Y., and Ikeda, K. (1985) Esterase-like activity of human serum albumin. V. Reaction with 2,4-dinitrophenyl diethyl phosphate Chem. Pharm. Bull. 33, 4995-5001
61. Ahmed, N., Dobler, D., Dean, M., and Thornalley, P. J. (2005) Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity J. Biol. Chem. 280, 5724-5732
62. Carter, D. C. and Ho, J. X. (1994) Structure of serum albumin Adv. Protein Chem. 45, 153-203